In the review by Abbas et al., they found several studies that have shown a decrease in nuclear staining with p16 in melanomas (50%–98% show loss) and that p16 could be used for differentiating melanoma from spitz nevi [95]. This evidence concerns the gene CDKN2A and melanoma.